Teratogenic interactions between methylmercury and mitomycin-C in mice

Area of Science:

• Toxicology
• Developmental Biology
• Teratology

Background:

• Methylmercury is a known teratogen, causing major malformations in developing fetuses.
• Mitomycin-C is a chemotherapeutic agent with teratogenic potential.
• Understanding combined exposure effects is crucial for risk assessment.

Purpose of the Study:

• To investigate the combined teratogenic effects of methylmercuric chloride and mitomycin-C in pregnant mice.
• To determine if methylmercury enhances mitomycin-C-induced malformations.
• To assess the additive effects on cleft palate formation.

Main Methods:

• Pregnant mice were administered varying doses of methylmercuric chloride orally on day 9 of gestation.
• A teratogenic dose of mitomycin-C was administered intraperitoneally on day 10.
• Fetal examination for major malformations, including cervical rib, vertebral anomalies, polydactyly, tail anomalies, and cleft palate.

Main Results:

• Combined treatment significantly increased the incidence of cervical rib, hindlimb polydactyly, and tail anomalies compared to mitomycin-C alone.
• Methylmercury demonstrated a dose-dependent enhancement of these specific mitomycin-C-induced malformations.
• A notable increase in cleft palate was observed with combined exposure, suggesting additive effects.

Conclusions:

• Methylmercury exposure potentiates mitomycin-C teratogenicity for specific malformations (cervical rib, polydactyly, tail anomaly) but not vertebral anomalies.
• The combined exposure of methylmercury and mitomycin-C leads to an additive effect in inducing cleft palate in mouse fetuses.
• These findings highlight the complex interactions between environmental toxins and chemotherapeutic agents during pregnancy.